|
Pfizer and Lilly preparing to resume Phase 3 chronic pain program for Tanezumab
|
23 March 2015 |
|
Pfizer to Acquire Hospira
|
06 February 2015 |
|
Acquisition provides Pfizer with a preclinical CMV vaccine candidate
|
09 January 2015 |
|
Pfizer expands rare disease research with establishment of gene therapy platform
|
08 December 2014 |
|
Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study
|
30 September 2014 |
|
Pfizer and Merck to collaborate on study evaluating novel anti-cancer combination regimen
|
26 August 2014 |
|
Pfizer enters into agreement to acquire Baxter's portfolio of marketed vaccines
|
31 July 2014 |
|
Pfizer to Acquire InnoPharma, Inc.
|
16 July 2014 |
|
CliniWorks forms a strategic alliance with Pfizer
|
10 July 2014 |
|
James C. Smith elected to Pfizer's Board of Directors
|
26 June 2014 |
|
Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration
|
18 June 2014 |
|
Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
|
16 June 2014 |
|
Pfizer and the Avon Foundation for Women announce $1 million grants program
|
29 May 2014 |
|
Pfizer brings frequent heartburn relief OTC with new Nexium® 24HR
|
27 May 2014 |
|
Pfizer reports first-quarter 2014 results
|
06 May 2014 |
|
Pfizer sends letter to Rt Hon David Cameron MP regarding commitments if proposed combination with AstraZeneca is completed
|
01 May 2014 |
|
Pfizer Confirms prior discussions with AstraZeneca
|
28 April 2014 |
|
Eliquis® (apixaban) reduced the risk of stroke and demonstrated fewer major bleeding events versus Warfarin
|
23 February 2014 |
|
Pfizer and Merck to collaborate on innovative anti-cancer combination studies
|
06 February 2014 |
|
Pfizer reports fourth-quarter and full-year 2013 results
|
29 January 2014 |